These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Estrogen response element and the promoter context of the human and mouse lactoferrin genes influence estrogen receptor alpha-mediated transactivation activity in mammary gland cells. Stokes K; Alston-Mills B; Teng C J Mol Endocrinol; 2004 Oct; 33(2):315-34. PubMed ID: 15525592 [TBL] [Abstract][Full Text] [Related]
47. A novel estradiol/estrogen receptor alpha-dependent transcriptional mechanism controls expression of the human prolactin receptor. Dong J; Tsai-Morris CH; Dufau ML J Biol Chem; 2006 Jul; 281(27):18825-36. PubMed ID: 16651265 [TBL] [Abstract][Full Text] [Related]
48. Constitutive expression of Rb associated protein 46 (RbAp46) reverts transformed phenotypes of breast cancer cells. Zhang TF; Yu SQ; Deuel TF; Wang ZY Anticancer Res; 2003; 23(5A):3735-40. PubMed ID: 14666671 [TBL] [Abstract][Full Text] [Related]
49. Cell cycle progression stimulated by tamoxifen-bound estrogen receptor-alpha and promoter-specific effects in breast cancer cells deficient in N-CoR and SMRT. Keeton EK; Brown M Mol Endocrinol; 2005 Jun; 19(6):1543-54. PubMed ID: 15802375 [TBL] [Abstract][Full Text] [Related]
50. Estrogen receptor-α directly regulates sensitivity to paclitaxel in neoadjuvant chemotherapy for breast cancer. Tokuda E; Seino Y; Arakawa A; Saito M; Kasumi F; Hayashi S; Yamaguchi Y Breast Cancer Res Treat; 2012 Jun; 133(2):427-36. PubMed ID: 21909982 [TBL] [Abstract][Full Text] [Related]
51. Scaffold attachment factor SAFB1 suppresses estrogen receptor alpha-mediated transcription in part via interaction with nuclear receptor corepressor. Jiang S; Meyer R; Kang K; Osborne CK; Wong J; Oesterreich S Mol Endocrinol; 2006 Feb; 20(2):311-20. PubMed ID: 16195251 [TBL] [Abstract][Full Text] [Related]
52. The SET oncoprotein promotes estrogen-induced transcription by facilitating establishment of active chromatin. Guo C; Meza-Sosa KF; Valle-Garcia D; Zhao G; Gao K; Yu L; Zhang H; Chen Y; Sun L; Rockowitz S; Wang S; Jiang S; Lieberman J Proc Natl Acad Sci U S A; 2023 Feb; 120(8):e2206878120. PubMed ID: 36791099 [TBL] [Abstract][Full Text] [Related]
53. Differential regulation of estrogen receptor α expression in breast cancer cells by metastasis-associated protein 1. Kang HJ; Lee MH; Kang HL; Kim SH; Ahn JR; Na H; Na TY; Kim YN; Seong JK; Lee MO Cancer Res; 2014 Mar; 74(5):1484-94. PubMed ID: 24413532 [TBL] [Abstract][Full Text] [Related]
54. MiR-301a-3p Suppresses Estrogen Signaling by Directly Inhibiting ESR1 in ERα Positive Breast Cancer. Lettlova S; Brynychova V; Blecha J; Vrana D; Vondrusova M; Soucek P; Truksa J Cell Physiol Biochem; 2018; 46(6):2601-2615. PubMed ID: 29763890 [TBL] [Abstract][Full Text] [Related]
55. A genome-wide study of the repressive effects of estrogen receptor beta on estrogen receptor alpha signaling in breast cancer cells. Williams C; Edvardsson K; Lewandowski SA; Ström A; Gustafsson JA Oncogene; 2008 Feb; 27(7):1019-32. PubMed ID: 17700529 [TBL] [Abstract][Full Text] [Related]
56. Estrogen receptor beta2 negatively regulates the transactivation of estrogen receptor alpha in human breast cancer cells. Zhao C; Matthews J; Tujague M; Wan J; Ström A; Toresson G; Lam EW; Cheng G; Gustafsson JA; Dahlman-Wright K Cancer Res; 2007 Apr; 67(8):3955-62. PubMed ID: 17440111 [TBL] [Abstract][Full Text] [Related]
57. Protein kinase A exhibits selective modulation of estradiol-dependent transcription in breast cancer cells that is associated with decreased ligand binding, altered estrogen receptor alpha promoter interaction, and changes in receptor phosphorylation. Al-Dhaheri MH; Rowan BG Mol Endocrinol; 2007 Feb; 21(2):439-56. PubMed ID: 17068199 [TBL] [Abstract][Full Text] [Related]
58. Estrogen Receptors alpha and beta as determinants of gene expression: influence of ligand, dose, and chromatin binding. Chang EC; Charn TH; Park SH; Helferich WG; Komm B; Katzenellenbogen JA; Katzenellenbogen BS Mol Endocrinol; 2008 May; 22(5):1032-43. PubMed ID: 18258689 [TBL] [Abstract][Full Text] [Related]
59. The Estrogen Receptor Cofactor SPEN Functions as a Tumor Suppressor and Candidate Biomarker of Drug Responsiveness in Hormone-Dependent Breast Cancers. Légaré S; Cavallone L; Mamo A; Chabot C; Sirois I; Magliocco A; Klimowicz A; Tonin PN; Buchanan M; Keilty D; Hassan S; Laperrière D; Mader S; Aleynikova O; Basik M Cancer Res; 2015 Oct; 75(20):4351-63. PubMed ID: 26297734 [TBL] [Abstract][Full Text] [Related]
60. The GPER1/SPOP axis mediates ubiquitination-dependent degradation of ERα to inhibit the growth of breast cancer induced by oestrogen. Zhang N; Sun P; Xu Y; Li H; Liu H; Wang L; Cao Y; Zhou K; TinghuaiWang Cancer Lett; 2021 Feb; 498():54-69. PubMed ID: 33069770 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]